Rabies Vaccine

• Prepared on cell cultures.
• Purified vero cell rabies vaccine.
• 1 dose for human use.

Abhayrab Powder for Injection side effects

• Pain, Joint pain, Injection site redness, Injection site swelling, Swelling of lymph nodes.

How to use Abhayrab Powder for Injection

• Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Abhayrab Powder for Injection works

• Abhayrab Injection is an inactivated vaccine. It helps develop immunity by forming antibodies, which are proteins that protect against infection caused by viruses.

• Pay Mode Terms: L/C (Letter of Credit)

• Rabies Vaccine B.P.
• PCEC rabies vaccine for human use.
• For intramuscular injection (1 ml/dose- 1 dose).
• For intradermal injection (0.1 ml/dose- 10 doses).
• To be used immediately after reconstitution with accompanying sterile water for injections.

Composition

• One vial of powder and solvent for solution for injection for one immunisation dose (1 ml) contains inactivated rabies virus (strain flury LEP), potency >2.5 IU.
• Host system primary chicken fibroblast cell cultures.

Other ingredients

• TRIS-(hydroxymethyl-)aminomethane, sodium chloride, EDTA (Titriplex III), potassium-L-glutamate, polygeline, saccharose, water for injections.

Presentation and contents by weight, volume or number of items

• After dissolution of the white lyophilisate (powder), a clear colourless solution is obtained.

Indications Active immunisation against rabies.

• Pre-exposure immunisation (preventative, prior to exposure) Immunisation prior to possible infection with rabies, particularly for vets, veterinary medicine students, animal keepers, hunters, forestry workers, animal handlers, butchers, personnel in rabies research laboratories etc., or prior to visits to areas in which rabies is endemic (rabies infected areas).
• Post-exposure treatment (after exposure) Treatment after contact with animals which are rabid or suspected to be rabid, or after contact with an inoculated rabies carcass.

Contraindications

• Immunisation prior to exposure It is advisable to avoid pre-exposure (prophylactic) immunisation in individuals with acute disorders requiring treatment. If complications arise after vaccination, this should be considered a contraindication for further administration of the same vaccine, until the causes of the complications have been clarified. In individuals with known allergy to one of the constituents of Rabipur, use of this vaccine is contraindicated.
• Treatment after exposure In view of the fact that rabies is a fatal disease, there are no contraindications to immunisation after suspected exposure.

• Do not freeze
• Protect from light
• Refer literature insert for dosage and administration